Amcor plc - Quarter Report: 2020 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2020
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 001-38932
AMCOR PLC
(Exact name of Registrant as specified in its charter)
Jersey | 98-1455367 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
83 Tower Road North
Warmley, Bristol BS30 8XP
United Kingdom
(Address of principal executive offices)
Registrant’s telephone number, including area code: +44 117 9753200
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
Ordinary Shares, Par Value $0.01 Per Share | AMCR | New York Stock Exchange | ||||||||||||
1.125% Guaranteed Senior Notes Due 2027 | AUKF/27 | New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
1
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer | ☒ | Emerging Growth Company | ☐ | ||||||||
Non-Accelerated Filer | ☐ | Smaller Reporting Company | ☐ | ||||||||
Accelerated Filer | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 4, 2020, the registrant had 1,568,481,519 ordinary shares, $0.01 par value, outstanding.
2
Amcor plc
Quarterly Report on Form 10-Q
Table of Contents
3
Cautionary Statement Regarding Forward-Looking Statements
Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this Quarterly Report on Form 10-Q refer to Amcor plc and its consolidated subsidiaries.
This Quarterly Report on Form 10-Q contains certain statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like "believe," "expect," "target", "project", "may," "could," "would," "approximately," "possible," "will," "should," "expect," "intend," "plan," "anticipate," "estimate," "potential," "outlook" or "continue," the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to:
•The continued financial and operational impacts of the 2019 Novel Coronavirus ("COVID-19") pandemic on Amcor and its customers, suppliers, employees and the geographic markets in which it and its customers operate;
•changes in consumer demand patterns and customer requirements in numerous industries;
•the loss of key customers, a reduction in their production requirements or consolidation among key customers;
•significant competition in the industries and regions in which we operate;
•the failure to successfully integrate acquisitions in the expected time frame;
•the inability to expand our current business effectively through either organic growth, including by product innovation, or acquisitions;
•challenges to or the loss of our intellectual property rights;
•challenging current and future global economic conditions;
•impacts of operating internationally;
•price fluctuations or shortages in the availability of raw materials, energy and other inputs, which could adversely affect our business;
•production, supply and other commercial risks, including counterparty credit risks, which may be exacerbated in times of economic downturn;
•a failure in our information technology systems;
•an inability to attract and retain key personnel;
•costs and liabilities related to current and future environmental and health and safety laws and regulations;
•labor disputes;
•the possibility that the phase out of the London Interbank Offered Rate ("LIBOR") causes our interest expense to increase;
•foreign exchange rate risk;
•an increase in interest rates;
•a downgrade in our credit rating that could increase our borrowing costs and negatively affect our financial condition and results of operations;
•a failure to hedge effectively against adverse fluctuations in interest rates and foreign exchange rates;
•a significant write-down of goodwill and/or other intangible assets;
•our need to maintain an effective system of internal control over financial reporting in the future;
•an inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face;
•litigation or regulatory developments;
•changing government regulations in environmental, health, and safety matters; and
•our ability to develop and successfully introduce new products and to develop, acquire and retain intellectual property rights.
These risks and uncertainties are supplemented by those identified from time to time in our filings with the Securities and Exchange Commission, including without limitation, those described under Part I, "Item 1A - Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
4
Part I - Financial Information
Item 1. Financial Statements
Amcor plc and Subsidiaries
Condensed Consolidated Statement of Income
(Unaudited)
Three Months Ended September 30, | ||||||||||||||
($ in millions, except per share data) | 2020 | 2019 | ||||||||||||
Net sales | $ | 3,097 | $ | 3,141 | ||||||||||
Cost of sales | (2,443) | (2,594) | ||||||||||||
Gross profit | 654 | 547 | ||||||||||||
Operating expenses: | ||||||||||||||
Selling, general, and administrative expenses | (329) | (371) | ||||||||||||
Research and development expenses | (26) | (26) | ||||||||||||
Restructuring and related expenses | (23) | (18) | ||||||||||||
Other income, net | — | 9 | ||||||||||||
Operating income | 276 | 141 | ||||||||||||
Interest income | 3 | 7 | ||||||||||||
Interest expense | (40) | (60) | ||||||||||||
Other non-operating income (loss), net | 3 | 8 | ||||||||||||
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies | 242 | 96 | ||||||||||||
Income tax expense | (61) | (22) | ||||||||||||
Equity in income (loss) of affiliated companies, net of tax | 19 | 2 | ||||||||||||
Income from continuing operations | 200 | 76 | ||||||||||||
Income (loss) from discontinued operations, net of tax | — | (8) | ||||||||||||
Net income | $ | 200 | $ | 68 | ||||||||||
Net (income) loss attributable to non-controlling interests | (2) | (2) | ||||||||||||
Net income attributable to Amcor plc | $ | 198 | $ | 66 | ||||||||||
Basic earnings per share: | ||||||||||||||
Income from continuing operations | $ | 0.127 | $ | 0.045 | ||||||||||
Loss from discontinued operations | — | (0.005) | ||||||||||||
Net income | $ | 0.127 | $ | 0.041 | ||||||||||
Diluted earnings per share: | ||||||||||||||
Income from continuing operations | $ | 0.126 | $ | 0.045 | ||||||||||
Loss from discontinued operations | — | (0.005) | ||||||||||||
Net income | $ | 0.126 | $ | 0.041 |
Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.
5
Amcor plc and Subsidiaries
Condensed Consolidated Statement of Comprehensive Income
(Unaudited)
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Net income | $ | 200 | $ | 68 | ||||||||||
Other comprehensive income (loss): | ||||||||||||||
Net gains (losses) on cash flow hedges, net of tax (a) | 4 | 1 | ||||||||||||
Foreign currency translation adjustments, net of tax (b) | 24 | (51) | ||||||||||||
Net investment hedge of foreign operations, net of tax (c) | — | (2) | ||||||||||||
Pension, net of tax (d) | 2 | 1 | ||||||||||||
Other comprehensive income (loss) | 30 | (51) | ||||||||||||
Total comprehensive income | 230 | 17 | ||||||||||||
Comprehensive (income) loss attributable to non-controlling interest | (2) | (2) | ||||||||||||
Comprehensive income attributable to Amcor plc | $ | 228 | $ | 15 | ||||||||||
(a) Tax (expense) benefit related to cash flow hedges | $ | (1) | $ | — | ||||||||||
(b) Tax (expense) benefit related to foreign currency translation adjustments | $ | 3 | $ | (2) | ||||||||||
(c) Tax (expense) benefit related to net investment hedge of foreign operations | $ | — | $ | 1 | ||||||||||
(d) Tax (expense) benefit related to pension adjustments | $ | 1 | $ | — |
See accompanying notes to condensed consolidated financial statements.
6
Amcor plc and Subsidiaries
Condensed Consolidated Balance Sheet
(Unaudited)
(in millions) | September 30, 2020 | June 30, 2020 | ||||||||||||
Assets | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ | 757 | $ | 743 | ||||||||||
Trade receivables, net | 1,673 | 1,616 | ||||||||||||
Inventories, net | 1,784 | 1,832 | ||||||||||||
Prepaid expenses and other current assets | 398 | 344 | ||||||||||||
Total current assets | 4,612 | 4,535 | ||||||||||||
Non-current assets: | ||||||||||||||
Investments in affiliated companies | — | 78 | ||||||||||||
Property, plant and equipment, net | 3,649 | 3,615 | ||||||||||||
Operating lease assets | 504 | 525 | ||||||||||||
Deferred tax assets | 145 | 135 | ||||||||||||
Other intangible assets, net | 1,951 | 1,994 | ||||||||||||
Goodwill | 5,382 | 5,339 | ||||||||||||
Employee benefit assets | 46 | 44 | ||||||||||||
Other non-current assets | 176 | 177 | ||||||||||||
Total non-current assets | 11,853 | 11,907 | ||||||||||||
Total assets | $ | 16,465 | $ | 16,442 | ||||||||||
Liabilities | ||||||||||||||
Current liabilities: | ||||||||||||||
Current portion of long-term debt | $ | 13 | $ | 11 | ||||||||||
Short-term debt | 225 | 195 | ||||||||||||
Trade payables | 1,808 | 2,171 | ||||||||||||
Accrued employee costs | 432 | 477 | ||||||||||||
Other current liabilities | 1,148 | 1,120 | ||||||||||||
Total current liabilities | 3,626 | 3,974 | ||||||||||||
Non-current liabilities: | ||||||||||||||
Long-term debt, less current portion | 6,361 | 6,028 | ||||||||||||
Operating lease liabilities | 445 | 466 | ||||||||||||
Deferred tax liabilities | 674 | 672 | ||||||||||||
Employee benefit obligations | 394 | 392 | ||||||||||||
Other non-current liabilities | 221 | 223 | ||||||||||||
Total non-current liabilities | 8,095 | 7,781 | ||||||||||||
Total liabilities | 11,721 | 11,755 | ||||||||||||
Commitments and contingencies (See Note 15) | ||||||||||||||
Shareholders' Equity | ||||||||||||||
Amcor plc shareholders’ equity: | ||||||||||||||
Ordinary shares ($0.01 par value) | ||||||||||||||
Authorized (9,000.0 shares) | ||||||||||||||
Issued (1,568.5 and 1,568.5 shares, respectively) | 16 | 16 | ||||||||||||
Additional paid-in capital | 5,481 | 5,480 | ||||||||||||
Retained earnings | 258 | 246 | ||||||||||||
Accumulated other comprehensive income (loss) | (1,019) | (1,049) | ||||||||||||
Treasury shares (4.9 and 6.7 shares, respectively) | (49) | (67) | ||||||||||||
Total Amcor plc shareholders' equity | 4,687 | 4,626 | ||||||||||||
Non-controlling interest | 57 | 61 | ||||||||||||
Total shareholders' equity | 4,744 | 4,687 | ||||||||||||
Total liabilities and shareholders' equity | $ | 16,465 | $ | 16,442 |
See accompanying notes to condensed consolidated financial statements.
7
Amcor plc and Subsidiaries
Condensed Consolidated Statement of Cash Flows
(Unaudited)
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Cash flows from operating activities: | ||||||||||||||
Net income | $ | 200 | $ | 68 | ||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
Depreciation, amortization and impairment | 145 | 184 | ||||||||||||
Net periodic benefit cost | 3 | 2 | ||||||||||||
Amortization of debt discount and deferred financing costs | 2 | 1 | ||||||||||||
Net gain on disposal of property, plant and equipment | (1) | — | ||||||||||||
Net loss on disposal of businesses | 6 | — | ||||||||||||
Equity in (income) loss of affiliated companies | (19) | (2) | ||||||||||||
Net foreign exchange (gain) loss | 1 | 7 | ||||||||||||
Share-based compensation | 14 | 6 | ||||||||||||
Other, net | (28) | 11 | ||||||||||||
Loss from hyperinflationary accounting for Argentine subsidiaries | 6 | 19 | ||||||||||||
Deferred income taxes, net | (3) | (37) | ||||||||||||
Dividends received from affiliated companies | 3 | — | ||||||||||||
Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency | (439) | (348) | ||||||||||||
Net cash (used in) provided by operating activities | (110) | (89) | ||||||||||||
Cash flows from investing activities: | ||||||||||||||
Purchase of property, plant and equipment and other intangible assets | (114) | (115) | ||||||||||||
Proceeds from divestiture | 138 | 397 | ||||||||||||
Proceeds from sales of property, plant and equipment and other intangible assets | 3 | 2 | ||||||||||||
Net cash (used in) provided by investing activities | 27 | 284 | ||||||||||||
Cash flows from financing activities: | ||||||||||||||
Proceeds from issuance of shares | 5 | 1 | ||||||||||||
Purchase of treasury shares | — | (10) | ||||||||||||
Proceeds from (purchase of) non-controlling interest | 1 | — | ||||||||||||
Proceeds from issuance of long-term debt | 1 | 229 | ||||||||||||
Repayment of long-term debt | (122) | (1,360) | ||||||||||||
Net borrowing/(repayment) of commercial paper | 350 | 1,054 | ||||||||||||
Net borrowing/(repayment) of short-term debt | 30 | (161) | ||||||||||||
Repayment of lease liabilities | (1) | — | ||||||||||||
Share buyback/cancellations | — | (58) | ||||||||||||
Dividends paid | (188) | (1) | ||||||||||||
Net cash (used in) provided by financing activities | 76 | (306) | ||||||||||||
Effect of exchange rates on cash and cash equivalents | 21 | (11) | ||||||||||||
Net increase (decrease) in cash and cash equivalents | 14 | (122) | ||||||||||||
Cash and cash equivalents balance at beginning of year | 743 | 602 | ||||||||||||
Cash and cash equivalents balance at end of period | $ | 757 | $ | 480 | ||||||||||
Supplemental cash flow information: | ||||||||||||||
Interest paid, net of amounts capitalized | $ | 22 | $ | 45 | ||||||||||
Income taxes paid | $ | 107 | $ | 54 | ||||||||||
Supplemental non-cash disclosures relating to investing and financing activities: | ||||||||||||||
Purchase of property and equipment, accrued but unpaid | $ | 58 | $ | 59 |
See accompanying notes to condensed consolidated financial statements.
8
Amcor plc and Subsidiaries
Condensed Consolidated Statement of Equity
(Unaudited)
($ in millions, except per share data) | Ordinary Shares | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Shares | Non-controlling Interest | Total | |||||||||||||||||||||||||||||||||||||
Balance as of June 30, 2019 | $ | 16 | $ | 6,008 | $ | 324 | $ | (722) | $ | (16) | $ | 65 | $ | 5,675 | ||||||||||||||||||||||||||||||
Net income (loss) | 66 | 2 | 68 | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | (51) | (51) | ||||||||||||||||||||||||||||||||||||||||||
Share buyback/cancellations | — | (58) | (58) | |||||||||||||||||||||||||||||||||||||||||
Dividends declared ($0.120 per share) | (196) | — | (196) | |||||||||||||||||||||||||||||||||||||||||
Options exercised and shares vested | (15) | 15 | — | |||||||||||||||||||||||||||||||||||||||||
Purchase of treasury shares | (10) | (10) | ||||||||||||||||||||||||||||||||||||||||||
Share-based compensation expense | 6 | 6 | ||||||||||||||||||||||||||||||||||||||||||
Cumulative adjustment related to the adoption of | 58 | 58 | ||||||||||||||||||||||||||||||||||||||||||
Balance as of September 30, 2019 | $ | 16 | $ | 5,941 | $ | 252 | $ | (773) | $ | (11) | $ | 67 | $ | 5,492 | ||||||||||||||||||||||||||||||
Balance as of June 30, 2020 | $ | 16 | $ | 5,480 | $ | 246 | $ | (1,049) | $ | (67) | $ | 61 | $ | 4,687 | ||||||||||||||||||||||||||||||
Net income (loss) | 198 | 2 | 200 | |||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | 30 | — | 30 | |||||||||||||||||||||||||||||||||||||||||
Dividends declared ($0.115 per share) | (181) | (7) | (188) | |||||||||||||||||||||||||||||||||||||||||
Options exercised and shares vested | (13) | 18 | 5 | |||||||||||||||||||||||||||||||||||||||||
Share-based compensation expense | 14 | 14 | ||||||||||||||||||||||||||||||||||||||||||
Change in non-controlling interest | 1 | 1 | ||||||||||||||||||||||||||||||||||||||||||
Cumulative adjustment related to the adoption of (1) | (5) | (5) | ||||||||||||||||||||||||||||||||||||||||||
Balance as of September 30, 2020 | $ | 16 | $ | 5,481 | 258 | $ | (1,019) | $ | (49) | $ | 57 | $ | 4,744 | |||||||||||||||||||||||||||||||
(1)Refer to Note 2, "New Accounting Guidance" for more information.
See accompanying notes to condensed consolidated financial statements.
9
Amcor plc and Subsidiaries
Notes to Condensed Consolidated Financial Statements
Note 1 - Nature of Operations and Basis of Presentation
Amcor plc ("Amcor" or the "Company") is a global packaging company that employs approximately 47,000 people across approximately 230 principal manufacturing sites in more than 40 countries. The Company develops and produces a broad range of packaging products including flexible packaging and rigid packaging containers.
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information. Consistent with these requirements, this Form 10-Q does not include all the information required by U.S. GAAP for complete financial statements. It is management's opinion, however, that all material adjustments (consisting of normal recurring accruals) have been made which are necessary for a fair statement of its financial position, results of operations and cash flows. For further information, this Form 10-Q should be read in conjunction with the Consolidated Financial Statements and accompanying Notes in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2020. There have been no material changes in the accounting policies followed by the Company during the current fiscal year other than the adoption of a new accounting pronouncement discussed below.
The Company reclassified prior year comparative figures in the condensed consolidated statement of cash flows to conform to the current year's presentation. This change in presentation did not have an impact on the Company’s financial condition or operating results.
Certain amounts in the Company's notes to condensed consolidated financial statements may not add or recalculate due to rounding.
Note 2 - New Accounting Guidance
Recently Adopted Accounting Standards
In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, which is guidance requiring financial assets, or a group of financial assets measured at amortized cost basis to be presented at the net amount expected to be collected when finalized using a loss methodology known as the current expected credit loss methodology ("CECL"). The allowance for credit losses is a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. This updated guidance impacts loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables and any other financial assets not excluded from the scope that have the contractual right to receive cash. The guidance was effective for the Company on July 1, 2020 and was adopted using the modified retrospective approach. The Company changed its disclosures related to credit losses; refer to Note 9, "Trade Receivables, Net".
The cumulative effect of the changes made to our consolidated July 1, 2020 balance sheet related to the adoption of CECL is as follows:
June 30, 2020 | Adjustments Due to Adoption | July 1, 2020 | ||||||||||||||||||
Trade receivables, net | $ | 1,616 | $ | (7) | $ | 1,609 | ||||||||||||||
Deferred tax assets | 135 | 2 | 137 | |||||||||||||||||
Retained earnings | 246 | (5) | 241 |
Accounting Standards Not Yet Adopted
In December 2019, the FASB issued updated guidance to simplify the accounting for income taxes by removing certain exceptions and improving the consistent application of U.S. GAAP in other tax accounting areas. This guidance is effective for annual reporting periods, and any interim periods within those annual periods, that begin after December 15, 2020 with early adoption permitted. Accordingly, the guidance will be effective for the Company on July 1, 2021. The Company is currently evaluating the impact that this guidance will have on its financial statements and related disclosures.
10
In March 2020, the FASB issued optional expedients and exceptions to ease the potential burden in accounting for reference rate reform related to contract modifications, hedging relationships, and other transactions that reference the London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discontinued, subject to meeting certain criteria. The Company is currently evaluating whether to elect the adoption of this optional guidance.
The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined that all other ASUs not yet adopted to be either not applicable or are expected to have minimal impact on the Company's consolidated financial statements at this time.
Note 3 - Discontinued Operations
On February 11, 2019, the Company received approval from the European Commission ("EC") for the acquisition of Bemis Company, Inc. ("Bemis"). A condition of the approval was an agreement to divest three Bemis medical packaging facilities located in the United Kingdom and Ireland ("EC Remedy"). Upon completion of the Bemis acquisition on June 11, 2019, the Company determined that the EC Remedy met the criteria to be classified as a discontinued operation, in accordance with ASC 205-20, "Discontinued Operations." The sale of the EC Remedy closed on August 8, 2019. The Company recorded a loss on the sale of $9 million, which is the result of the reclassification of accumulated foreign currency translation amounts from accumulated other comprehensive income to earnings from discontinued operations upon sale of the EC Remedy.
The following table summarizes the results of the EC Remedy, classified as discontinued operations, from July 1, 2019 until the sale of the EC Remedy on August 8, 2019:
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Net sales | $ | — | $ | 16 | ||||||||||
Income (loss) from discontinued operations | — | (7) | ||||||||||||
Tax expense on discontinued operations | — | (1) | ||||||||||||
Income (loss) from discontinued operations, net of tax | $ | — | $ | (8) |
Note 4 - Restructuring Plans
2019 Bemis Integration Plan
In connection with the acquisition of Bemis, the Company initiated restructuring activities in the fourth quarter of 2019 aimed at integrating and optimizing the combined organization. As previously announced, the Company continues to target realizing approximately $180 million of pre-tax synergies driven by procurement, supply chain, and general and administrative savings by the end of fiscal year 2022.
The Company's total 2019 Bemis Integration Plan pre-tax integration costs are expected to be approximately $200 million. The total 2019 Bemis Integration Plan costs include $165 million of restructuring and related expenses and $35 million of general integration expenses. The restructuring and related expenses are comprised of approximately $90 million in employee related expenses, $25 million in fixed asset related expenses, $20 million in other restructuring and $30 million in restructuring related expenses. The breakdown of expenses incurred to date is broadly proportionate to the breakdown by major type of the estimated overall program expenses. The Company estimates that approximately $150 million of the $200 million total integration costs will result in cash expenditures, of which $115 million relate to restructuring and related expenditures. Cash payments for the three months ended September 30, 2020 were $18 million, of which $14 million were payments related to restructuring and related expenditures. Cash payments of approximately $50 million to $55 million are expected for the balance of the fiscal year with $40 million to $45 million representing payments for restructuring and related expenses. The 2019 Bemis Integration Plan relates to the Flexibles segment and Corporate and is expected to be completed by the end of fiscal year 2022.
Restructuring related costs are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. General integration costs are not linked to restructuring. The Company believes the disclosure of restructuring related costs provides more information on the total cost of our 2019 Bemis Integration Plan. The restructuring related costs relate primarily to the closure of facilities and include costs to replace graphics, train new employees on relocated equipment and anticipated losses on sale of closed facilities.
11
2018 Rigid Packaging Restructuring Plan
On August 21, 2018, the Company announced a restructuring plan in Amcor Rigid Packaging ("2018 Rigid Packaging Restructuring Plan") aimed at reducing structural costs and optimizing the footprint. The Plan includes the closures of manufacturing facilities and headcount reductions to achieve manufacturing footprint optimization and productivity improvements as well as overhead cost reductions.
The Company's total 2018 Rigid Packaging Restructuring Plan pre-tax restructuring costs are expected to be approximately $110 million with the main component being the cost to exit manufacturing facilities and employee related costs. The Company estimates that approximately $70 million of the $110 million total costs will result in cash expenditures. Cash payments for the three months ended September 30, 2020 were $10 million, with approximately $5 million to $10 million expected during the remainder of the fiscal year. The 2018 Rigid Packaging Restructuring Plan is expected to be substantially completed during fiscal year 2021.
Other Restructuring Plans
The Company has entered into other individually immaterial restructuring plans ("Other Restructuring Plans"). The Company's restructuring charge related to these plans was approximately $9 million and zero for the three months ended September 30, 2020 and 2019, respectively. The Company's total incurred restructuring charge for Other Restructuring Plans primarily relates to the Flexibles reporting segment.
Consolidated Amcor Restructuring Plans
The total costs incurred from the beginning of the Company's material restructuring plans are as follows:
($ in millions) | 2018 Rigid Packaging Restructuring Plan | 2019 Bemis Integration Plan | Other Restructuring Plans | Total Restructuring and Related Expenses (1) | ||||||||||||||||||||||
Fiscal year 2019 net charges to earnings | $ | 64 | $ | 48 | $ | 19 | $ | 131 | ||||||||||||||||||
Fiscal year 2020 net charges to earnings | 37 | 60 | 18 | 115 | ||||||||||||||||||||||
Fiscal year 2021 first quarter net charges to earnings | 8 | 6 | 9 | 23 | ||||||||||||||||||||||
Expense incurred to date | $ | 109 | $ | 115 | $ | 45 | $ | 269 |
(1)Total restructuring and related expenses includes restructuring related costs from the 2019 Bemis Integration Plan of $15 million and $1 million for fiscal year 2020 and first quarter of fiscal year 2021, respectively.
An analysis of the Company's restructuring plan liability is as follows:
($ in millions) | Employee Costs | Fixed Asset Related Costs | Other Costs | Total Restructuring Costs | ||||||||||||||||||||||
Liability balance at June 30, 2020 | $ | 70 | $ | 3 | $ | 12 | $ | 85 | ||||||||||||||||||
Net charges to earnings | 12 | 1 | 9 | 22 | ||||||||||||||||||||||
Cash paid | (15) | (4) | (7) | (26) | ||||||||||||||||||||||
Foreign currency translation | (2) | — | — | (2) | ||||||||||||||||||||||
Liability balance at September 30, 2020 | $ | 65 | $ | — | $ | 14 | $ | 79 |
The costs related to restructuring activities have been presented on the consolidated statement of income as restructuring and related expenses. The accruals related to restructuring activities have been recorded on the unaudited condensed consolidated balance sheet under other current liabilities and other non-current liabilities.
12
Note 5 - Inventories, Net
Inventories, net are summarized as follows:
($ in millions) | September 30, 2020 | June 30, 2020 | ||||||||||||
Raw materials and supplies | $ | 807 | $ | 809 | ||||||||||
Work in process and finished goods | 1,087 | 1,127 | ||||||||||||
Less: inventory reserves | (110) | (104) | ||||||||||||
Total inventories, net | $ | 1,784 | $ | 1,832 |
Note 6 - Goodwill and Other Intangible Assets, Net
Goodwill
Changes in the carrying amount of goodwill attributable to each reportable segment are as follows:
($ in millions) | Flexibles Segment | Rigid Packaging Segment | Total | |||||||||||||||||
Balance as of June 30, 2020 | $ | 4,369 | $ | 970 | $ | 5,339 | ||||||||||||||
Currency translation | 41 | 2 | 43 | |||||||||||||||||
Balance as of September 30, 2020 | $ | 4,410 | $ | 972 | $ | 5,382 |
There is a $4 million accumulated goodwill impairment loss in the Rigid Packaging reportable segment as of September 30, 2020 and June 30, 2020.
Other Intangible Assets, Net
The components of intangible assets are as follows:
September 30, 2020 | ||||||||||||||||||||
($ in millions) | Gross Carrying Amount | Accumulated Amortization and Impairment | Net Carrying Amount | |||||||||||||||||
Customer relationships | $ | 1,963 | $ | (305) | $ | 1,658 | ||||||||||||||
Computer software | 223 | (141) | 82 | |||||||||||||||||
Other (1) | 324 | (113) | 211 | |||||||||||||||||
Balance as of | $ | 2,509 | $ | (558) | $ | 1,951 |
June 30, 2020 | ||||||||||||||||||||
($ in millions) | Gross Carrying Amount | Accumulated Amortization and Impairment | Net Carrying Amount | |||||||||||||||||
Customer relationships | $ | 1,957 | $ | (264) | $ | 1,693 | ||||||||||||||
Computer software | 218 | (131) | 87 | |||||||||||||||||
Other (1) | 321 | (107) | 214 | |||||||||||||||||
Balance as of | $ | 2,496 | $ | (502) | $ | 1,994 |
(1)Other includes $16 million for both September 30, 2020 and June 30, 2020 of acquired intellectual property assets not yet being amortized as the related R&D projects have not yet been completed.
Amortization expense for intangible assets during the three months ended September 30, 2020 and 2019 were $46 million and $74 million, respectively.
13
Note 7 - Fair Value Measurements
The fair values of the Company’s financial assets and financial liabilities listed below reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price).
The Company’s non-derivative financial instruments primarily include cash and cash equivalents, trade receivables, trade payables, short-term debt and long-term debt. At September 30, 2020 and June 30, 2020, the carrying value of these financial instruments, excluding long-term debt, approximates fair value because of the short-term nature of these instruments.
The fair value of long-term debt with variable interest rates approximates its carrying value. The fair value of the Company’s long-term debt with fixed interest rates is based on market prices, if available, or expected future cash flows discounted at the current interest rate for financial liabilities with similar risk profiles.
The carrying values and estimated fair values of long-term debt with fixed interest rates (excluding capital leases) were as follows:
September 30, 2020 | June 30, 2020 | |||||||||||||||||||||||||
Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||||||||||||
($ in millions) | (Level 2) | (Level 2) | ||||||||||||||||||||||||
Total long-term debt with fixed interest rates (excluding commercial paper and finance leases) | $ | 3,527 | $ | 3,779 | $ | 3,599 | $ | 3,793 |
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
Additionally, the Company measures and records certain assets and liabilities, including derivative instruments and contingent purchase consideration liabilities, at fair value. The following table summarizes the fair value of these instruments, which are measured at fair value on a recurring basis, by level, within the fair value hierarchy:
September 30, 2020 | ||||||||||||||||||||||||||
($ in millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Commodity contracts | $ | — | $ | 2 | $ | — | $ | 2 | ||||||||||||||||||
Forward exchange contracts | — | 6 | — | 6 | ||||||||||||||||||||||
Interest rate swaps | — | 31 | — | 31 | ||||||||||||||||||||||
Total assets measured at fair value | $ | — | $ | 39 | $ | — | $ | 39 | ||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Contingent purchase consideration liabilities | $ | — | $ | — | $ | 15 | $ | 15 | ||||||||||||||||||
Commodity contracts | — | 3 | — | 3 | ||||||||||||||||||||||
Forward exchange contracts | — | 13 | — | 13 | ||||||||||||||||||||||
Cross currency interest rate swaps | — | 5 | — | 5 | ||||||||||||||||||||||
Total liabilities measured at fair value | $ | — | $ | 20 | $ | 15 | $ | 35 |
14
June 30, 2020 | ||||||||||||||||||||||||||
($ in millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Forward exchange contracts | — | 8 | — | 8 | ||||||||||||||||||||||
Interest rate swaps | — | 32 | — | 32 | ||||||||||||||||||||||
Total assets measured at fair value | $ | — | $ | 40 | $ | — | $ | 40 | ||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Contingent purchase consideration liabilities | $ | — | $ | — | $ | 15 | $ | 15 | ||||||||||||||||||
Commodity contracts | — | 7 | — | 7 | ||||||||||||||||||||||
Forward exchange contracts | — | 17 | — | 17 | ||||||||||||||||||||||
Total liabilities measured at fair value | $ | — | $ | 24 | $ | 15 | $ | 39 |
The fair value of the commodity contracts was determined using a discounted cash flow analysis based on the terms of the contracts and observed market forward prices discounted at a currency-specific rate. Forward exchange contract fair values were determined based on quoted prices for similar assets and liabilities in active markets using inputs such as currency rates and forward points. The fair value of the interest rate swaps was determined using a discounted cash flow method based on market-based swap yield curves, taking into account current interest rates.
Contingent consideration obligations arise from business acquisitions. The Company's contingent consideration liabilities consist of an $11 million liability that is contingent on future royalty income generated by Discma AG, a subsidiary acquired in March 2017, with the $4 million balance relating to consideration for another small business acquisition where payment is contingent on the Company vacating a certain property. The fair value of the contingent purchase consideration liabilities was determined for each arrangement individually. The fair value was determined using the income approach with significant inputs that are not observable in the market. Key assumptions include the discount rates consistent with the level of risk of achievement and probability adjusted financial projections. The expected outcomes are recorded at net present value, which requires adjustment over the life for changes in risks and probabilities. Changes arising from modifications in forecast related to contingent consideration are expected to be immaterial.
The fair value of contingent purchase consideration liabilities is included in other current liabilities and other non-current liabilities in the unaudited condensed consolidated balance sheet.
Assets and Liabilities Measured and Recorded at Fair Value on a Nonrecurring Basis
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis as required by U.S. GAAP. The Company measures certain assets, including technology intangible assets, equity method investments and other intangible assets at fair value on a nonrecurring basis when they are deemed to be other than temporarily impaired. The fair values of these assets are determined, when applicable, based on valuation techniques using the best information available, and may include quoted market prices, market comparables and discounted cash flow projections.
The Company sold its equity method investment in AMVIG Holdings Limited ("AMVIG") on September 30, 2020. Refer to Note 16, "Disposals".
Similar to the manner in which it tests other intangible assets, the Company tests technology intangibles for impairment when facts and circumstances indicate the carrying value may not be recoverable from their future cash flows. During the three months ended September 30, 2020 and 2019, there were no triggering events and therefore no technology intangible impairment charges recorded.
15
Note 8 - Derivative Instruments
The Company periodically uses derivatives and other financial instruments to hedge exposures to interest rate, commodity and currency risks. The Company does not hold or issue financial instruments for speculative or trading purposes. For hedges that meet the hedge accounting criteria, the Company, at inception, formally designates and documents the instrument as a fair value hedge or a cash flow hedge of a specific underlying exposure. On an ongoing basis, the Company assesses and documents that its hedges have been and are expected to continue to be highly effective.
Interest Rate Risk
The Company’s policy is to manage exposure to interest rate risk by maintaining a mixture of fixed-rate and variable-rate debt, monitoring global interest rates and, where appropriate, hedging floating interest rate exposure or debt at fixed interest rates through various interest rate derivative instruments, including, but not limited to, interest rate swaps, cross-currency interest rate swaps, and interest rate locks. For interest rate swaps that are accounted for as fair value hedges, changes in the fair value of both the hedging instruments and the underlying debt obligations are immediately recognized in interest expense. Changes in the fair value of interest rate swaps that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statement of income under other non-operating income (loss), net.
At September 30, 2020 and June 30, 2020, the Company had a notional amount of $100 million cross-currency interest rate swaps outstanding. The Company did not designate the swaps as hedging instruments and thus changes in fair value were immediately recognized in earnings.
As of September 30, 2020, and June 30, 2020, the total notional amount of the Company’s receive-fixed/pay-variable interest rate swaps accounted for as fair value hedges was $852 million and $837 million, respectively.
Foreign Currency Risk
The Company manufactures and sells its products and finances operations in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. The purpose of the Company’s foreign currency hedging program is to manage the volatility associated with the changes in exchange rates.
To manage this exchange rate risk, the Company utilizes forward contracts. Contracts that qualify for hedge accounting are designated as cash flow hedges of certain forecasted transactions denominated in foreign currencies. The effective portion of the changes in fair value of these instruments is reported in accumulated other comprehensive income (loss) ("AOCI") and reclassified into earnings in the same financial statement line item and in the same period or periods during which the related hedged transactions affect earnings. The ineffective portion is recognized in earnings over the life of the hedging relationship in the same unaudited condensed consolidated statement of income line item as the underlying hedged item. Changes in the fair value of forward contracts that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statement of income.
As of September 30, 2020, and June 30, 2020, the notional amount of the outstanding forward contracts was $1.3 billion and $1.6 billion, respectively.
The Company manages its currency exposure related to the net assets of its foreign operations primarily through borrowings denominated in the relevant currency. Foreign currency gains and losses from the remeasurement of external borrowings designated as net investment hedges of a foreign operation are recognized in AOCI, to the extent that the hedge is effective. The ineffective portion is immediately recognized in other non-operating income (loss), net in the unaudited condensed consolidated statement of income. When a hedged net investment is disposed of, a percentage of the cumulative amount recognized in AOCI in relation to the hedged net investment is recognized in the unaudited condensed consolidated statement of income as part of the profit or loss on disposal.
Commodity Risk
Certain raw materials used in the Company's production processes are subject to price volatility caused by weather, supply conditions, political and economic variables and other unpredictable factors. The Company's policy is to minimize exposure to price volatility by passing through the commodity price risk to customers, including the use of fixed price swaps. The Company purchases on behalf of customers fixed price commodity swaps to offset the exposure of price volatility on the underlying sales contracts. These instruments are cash closed out on maturity and the related cost or benefit is passed through to customers. Information about commodity price exposure is derived from supply forecasts submitted by customers and these
16
exposures are hedged by a central treasury unit. Changes in the fair value of commodity hedges are recognized in AOCI. The cumulative amount of the hedge is recognized in the unaudited condensed consolidated statement of income when the forecast transaction is realized.
At September 30, 2020 and June 30, 2020, the Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:
September 30, 2020 | June 30, 2020 | |||||||||||||
Commodity | Volume | Volume | ||||||||||||
Aluminum | 39,569 tons | 44,944 tons | ||||||||||||
PET resin | 21,256,000 lbs. | 26,006,000 lbs. |
The following tables provide the location of derivative instruments in the unaudited condensed consolidated balance sheet:
($ in millions) | Balance Sheet Location | September 30, 2020 | June 30, 2020 | |||||||||||||||||
Assets | ||||||||||||||||||||
Derivatives in cash flow hedging relationships: | ||||||||||||||||||||
Commodity contracts | Other current assets | $ | 2 | $ | — | |||||||||||||||
Forward exchange contracts | Other current assets | 2 | 2 | |||||||||||||||||
Derivatives not designated as hedging instruments: | ||||||||||||||||||||
Forward exchange contracts | Other current assets | 4 | 6 | |||||||||||||||||
Total current derivative contracts | 8 | 8 | ||||||||||||||||||
Derivatives in fair value hedging relationships: | ||||||||||||||||||||
Interest rate swaps | Other non-current assets | 31 | 32 | |||||||||||||||||
Total non-current derivative contracts | 31 | 32 | ||||||||||||||||||
Total derivative asset contracts | $ | 39 | $ | 40 | ||||||||||||||||
Liabilities | ||||||||||||||||||||
Derivatives in cash flow hedging relationships: | ||||||||||||||||||||
Commodity contracts | Other current liabilities | $ | 3 | $ | 7 | |||||||||||||||
Forward exchange contracts | Other current liabilities | 5 | 3 | |||||||||||||||||
Derivatives not designated as hedging instruments: | ||||||||||||||||||||
Forward exchange contracts | Other current liabilities | 8 | 14 | |||||||||||||||||
Cross currency interest rate swaps | Other current liabilities | 5 | — | |||||||||||||||||
Total current derivative contracts | 20 | 24 | ||||||||||||||||||
Total non-current derivative contracts | — | — | ||||||||||||||||||
Total derivative liability contracts | $ | 20 | $ | 24 |
Certain derivative financial instruments are subject to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments within the unaudited condensed consolidated balance sheet.
17
The following tables provide the effects of derivative instruments on AOCI and in the unaudited condensed consolidated statement of income:
Location of Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | |||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||||||||
Derivatives in cash flow hedging relationships | ||||||||||||||||||||
Commodity contracts | Cost of sales | $ | (3) | $ | (2) | |||||||||||||||
Treasury locks | Interest expense | (1) | — | |||||||||||||||||
Total | $ | (4) | $ | (2) |
Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statement of Income | Gain (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments | |||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||||||||
Derivatives not designated as hedging instruments | ||||||||||||||||||||
Forward exchange contracts | Other income, net | $ | 7 | $ | — | |||||||||||||||
Cross currency interest rate swaps | Other income, net | (4) | (3) | |||||||||||||||||
Total | $ | 3 | $ | (3) |
Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statement of Income | Gain (Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships | |||||||||||||||||||
Three Months Ended September 30, | ||||||||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||||||||
Derivatives in fair value hedging relationships | ||||||||||||||||||||
Interest rate swaps | Interest expense | $ | (1) | $ | — | |||||||||||||||
Total | $ | (1) | $ | — |
18
Note 9 - Trade Receivables, Net
Trade receivables, net is summarized as follows:
($ in millions) | September 30, 2020 | June 30, 2020 | ||||||||||||
Trade receivables, gross | $ | 1,706 | $ | 1,651 | ||||||||||
Less: Allowance for doubtful accounts | (33) | (35) | ||||||||||||
Trade receivables, net | $ | 1,673 | $ | 1,616 |
Allowance for Doubtful Accounts
The changes in allowance for doubtful accounts, including expected credit losses, during the three months ended September 30, 2020 and 2019 were as follows:
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Balance as of June 30 | $ | (35) | $ | (34) | ||||||||||
Impact of adoption of ("CECL") (1) | (7) | — | ||||||||||||
Recoveries/(charges) to income | 4 | (4) | ||||||||||||
Write-offs | 6 | — | ||||||||||||
Foreign currency and other | (1) | 3 | ||||||||||||
Balance as of September 30 | $ | (33) | $ | (35) |
(1)Refer to Note 2, "New Accounting Guidance" for more information.
The Company determines its allowance for doubtful accounts using a combination of factors, including customer creditworthiness, past transaction history with the customer and changes in customer payment terms or practices. In addition, overall historical collection experience, current economic industry trends and a review of the current status of trade accounts receivable are considered when determining the required allowance for doubtful accounts.
19
Note 10 - Components of Net Periodic Benefit Cost
Net periodic benefit cost for benefit plans include the following components:
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Service cost | $ | 6 | $ | 6 | ||||||||||
Interest cost | 10 | 12 | ||||||||||||
Expected return on plan assets | (15) | (18) | ||||||||||||
Amortization of net loss | 2 | 2 | ||||||||||||
Net periodic benefit cost | $ | 3 | $ | 2 |
Service cost is included in operating income. All other components of net periodic benefit cost other than service cost are recorded within other non-operating income (loss), net.
Note 11 - Income Taxes
The Company computes its provision for income taxes by applying the estimated annual effective tax rate to year to date income before income taxes and equity in income of affiliated companies and adjusts for discrete tax items recorded in the period.
The provision for income taxes for the three months ended September 30, 2020 and 2019 is based on our projected annual effective tax rate for the respective fiscal years, adjusted for specific items that are required to be recognized in the period in which they are incurred.
Income tax expense for the three months ended September 30, 2020 and 2019 is $61 million and $22 million, respectively.
The effective tax rate for the three months ended September 30, 2020 increased by 2.3 percentage points compared to the three months ended September 30, 2019, from 22.9% to 25.2%. The increase in the income tax provision and the effective tax rate was primarily related to lower tax benefits on integration and restructuring costs and the increase of operating income earned in higher tax jurisdictions.
20
Note 12 - Shareholders' Equity
The changes in ordinary and treasury shares during the three months ended September 30, 2020 and 2019 were as follows:
Ordinary Shares | Treasury Shares | |||||||||||||||||||||||||
(shares and $ in millions) | Number of Shares | Amount | Number of Shares | Amount | ||||||||||||||||||||||
Balance as of June 30, 2019 | 1,626 | $ | 16 | 1 | $ | (16) | ||||||||||||||||||||
Share buy-back/cancellations | (6) | — | ||||||||||||||||||||||||
Options exercised and shares vested | (1) | 15 | ||||||||||||||||||||||||
Purchase of treasury shares | 1 | (10) | ||||||||||||||||||||||||
Balance as of September 30, 2019 | 1,620 | $ | 16 | 1 | $ | (11) | ||||||||||||||||||||
Balance as of June 30, 2020 | 1,569 | $ | 16 | 7 | $ | (67) | ||||||||||||||||||||
Options exercised and shares vested | (2) | 18 | ||||||||||||||||||||||||
Balance as of September 30, 2020 | 1,569 | $ | 16 | 5 | $ | (49) |
The changes in the components of accumulated other comprehensive income (loss) during the three months ended September 30, 2020 and 2019 were as follows:
Foreign Currency Translation | Net Investment Hedge | Pension | Effective Derivatives | Total Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||
($ in millions) | (Net of Tax) | (Net of Tax) | (Net of Tax) | (Net of Tax) | ||||||||||||||||||||||||||||
Balance as of June 30, 2019 | $ | (609) | $ | (11) | $ | (90) | $ | (12) | $ | (722) | ||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications | (60) | (2) | — | (1) | (63) | |||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | 9 | — | 1 | 2 | 12 | |||||||||||||||||||||||||||
Net current period other comprehensive income (loss) | (51) | (2) | 1 | 1 | (51) | |||||||||||||||||||||||||||
Balance as of September 30, 2019 | $ | (660) | $ | (13) | $ | (88) | $ | (12) | $ | (773) | ||||||||||||||||||||||
Balance as of June 30, 2020 | $ | (896) | $ | (14) | $ | (106) | $ | (34) | $ | (1,049) | ||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications | (1) | — | (1) | 1 | (1) | |||||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | 25 | — | 3 | 3 | 31 | |||||||||||||||||||||||||||
Net current period other comprehensive income (loss) | 24 | — | 2 | 4 | 30 | |||||||||||||||||||||||||||
Balance as of September 30, 2020 | $ | (872) | $ | (14) | $ | (104) | $ | (30) | $ | (1,019) |
21
The following tables provide details of amounts reclassified from accumulated other comprehensive income (loss):
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Amortization of pension: | ||||||||||||||
Amortization of prior service credit | $ | — | $ | (1) | ||||||||||
Amortization of actuarial loss | 2 | 2 | ||||||||||||
Total before tax effect | 2 | 1 | ||||||||||||
Tax benefit on amounts reclassified into earnings | 1 | — | ||||||||||||
Total net of tax | $ | 3 | $ | 1 | ||||||||||
(Gains) losses on cash flow hedges: | ||||||||||||||
Commodity contracts | $ | 3 | $ | 2 | ||||||||||
Treasury locks | 1 | — | ||||||||||||
Total before tax effect | 4 | 2 | ||||||||||||
Tax benefit on amounts reclassified into earnings | — | — | ||||||||||||
Total net of tax | $ | 4 | $ | 2 | ||||||||||
(Gains) losses on foreign currency translation: | ||||||||||||||
Foreign currency translation adjustment (1) | $ | 25 | $ | 9 | ||||||||||
Total before tax effect | 25 | 9 | ||||||||||||
Tax benefit on amounts reclassified into earnings | — | — | ||||||||||||
Total net of tax | $ | 25 | $ | 9 |
(1) During the three months ended September 30, 2020, the Company recorded a gain on disposal of AMVIG and other non-core businesses. Upon completion of the sales, $25 million of accumulated foreign currency translation was transferred from accumulated other comprehensive income to earnings. Refer to Note 16, "Disposals" for more information on disposals. During the three months ended September 30, 2019, the Company recorded a loss on the sale of the EC Remedy of $9 million, which is the result of the reclassification of accumulated foreign currency translation amounts from accumulated other comprehensive income to earnings. Refer to Note 3, "Discontinued Operations" for more information on the sale of the EC Remedy.
22
Note 13 - Segments
The Company's business is organized and presented in the two reportable segments outlined below:
Flexibles: Consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries.
Rigid Packaging: Consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads and personal care items and plastic caps for a wide variety of applications.
Other consists of the Company's undistributed corporate expenses including executive and functional compensation costs, equity method investments, intercompany eliminations and other business activities.
The accounting policies of the reportable segments are the same as those in the consolidated financial statements. During the first quarter of fiscal 2021, the Company has revised the presentation of adjusted earnings before interest and tax ("Adjusted EBIT") from continuing operations in the reportable segments to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. The Company refines its expense allocation methodologies to the reportable segments periodically as more refined information becomes available and to align with industry or market changes. Corporate expenses are allocated to the reportable segments based primarily on direct attribution. Prior periods have been recast to conform to the new cost allocation methodology.
23
The following table presents information about reportable segments:
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Sales including intersegment sales | ||||||||||||||
Flexibles | $ | 2,400 | $ | 2,431 | ||||||||||
Rigid Packaging | 698 | 711 | ||||||||||||
Other | — | — | ||||||||||||
Total sales including intersegment sales | 3,098 | 3,142 | ||||||||||||
Intersegment sales | ||||||||||||||
Flexibles | 1 | 1 | ||||||||||||
Rigid Packaging | — | — | ||||||||||||
Other | — | — | ||||||||||||
Total intersegment sales | 1 | 1 | ||||||||||||
Net sales | $ | 3,097 | $ | 3,141 | ||||||||||
Adjusted EBIT from continuing operations | ||||||||||||||
Flexibles | $ | 312 | $ | 283 | ||||||||||
Rigid Packaging | 72 | 69 | ||||||||||||
Other | (27) | (17) | ||||||||||||
Adjusted EBIT from continuing operations | 358 | 335 | ||||||||||||
Less: Material restructuring programs (1) | (14) | (17) | ||||||||||||
Less: Material acquisition costs and other (2) | (9) | (84) | ||||||||||||
Less: Amortization of acquired intangible assets from business combinations (3) | (41) | (68) | ||||||||||||
Less: Impact of hyperinflation (4) | (4) | (15) | ||||||||||||
Add: Net gain on disposals (5) | 9 | — | ||||||||||||
EBIT from continuing operations | 298 | 151 | ||||||||||||
Interest income | 3 | 7 | ||||||||||||
Interest expense | (40) | (60) | ||||||||||||
Equity in (income) loss of affiliated companies, net of tax | (19) | (2) | ||||||||||||
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies | $ | 242 | $ | 96 |
(1)Material restructuring programs includes the 2018 Rigid Packaging Restructuring Plan and the 2019 Bemis Integration Plan for the three months ended September 30, 2020 and 2019. Refer to Note 4, "Restructuring Plans," for more information about the Company's restructuring plans.
(2)Material acquisition costs and other includes Bemis transaction related costs and integration costs not qualifying as exit costs for the three months ended September 30, 2020. Material acquisition costs and other includes $58 million amortization of Bemis acquisition related inventory fair value step-up and $26 million of Bemis transaction related costs and integration costs not qualifying as exit costs for the three months ended September 30, 2019.
(3)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from acquisitions impacting the periods presented, including $26 million of sales backlog amortization for the three months ended September 30, 2019 from the Bemis acquisition.
(4)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
(5)Net gain on disposals includes the gain realized upon the disposal of AMVIG and other non-core businesses. Refer to Note 16, "Disposals" for more information about the Company's disposals.
24
The following tables disaggregates sales, excluding intersegment sales, information by geography in which the Company operates based on manufacturing or selling operation:
Net Sales | Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
2020 | 2019 | |||||||||||||||||||||||||||||||||||||
($ in millions) | Flexibles | Rigid Packaging | Total | Flexibles | Rigid Packaging | Total | ||||||||||||||||||||||||||||||||
North America | $ | 900 | $ | 587 | $ | 1,486 | $ | 908 | $ | 585 | $ | 1,493 | ||||||||||||||||||||||||||
Latin America | 227 | 111 | 338 | 263 | 126 | 389 | ||||||||||||||||||||||||||||||||
Europe | 894 | — | 894 | 886 | — | 886 | ||||||||||||||||||||||||||||||||
Asia Pacific | 378 | — | 378 | 374 | — | 374 | ||||||||||||||||||||||||||||||||
Net sales | $ | 2,399 | $ | 698 | $ | 3,097 | $ | 2,430 | $ | 711 | $ | 3,141 |
25
Note 14 - Earnings Per Share Computations
The Company applies the two-class method when computing its earnings per share ("EPS"), which requires that net income per share for each class of share be calculated assuming all of the Company's net income is distributed as dividends to each class of share based on their contractual rights.
Basic EPS is computed by dividing net income available to ordinary shareholders by the weighted-average number of ordinary shares outstanding after excluding the ordinary shares to be repurchased using forward contracts. Diluted EPS includes the effects of share options, restricted shares, performance rights, performance shares and share rights, if dilutive.
Three Months Ended September 30, | ||||||||||||||
(in millions, except per share amounts) | 2020 | 2019 | ||||||||||||
Numerator | ||||||||||||||
Net income attributable to Amcor plc | $ | 198 | $ | 66 | ||||||||||
Distributed and undistributed earnings attributable to shares to be repurchased | — | — | ||||||||||||
Net income available to ordinary shareholders of Amcor plc—basic and diluted | $ | 198 | $ | 66 | ||||||||||
Net income available to ordinary shareholders of Amcor plc from continuing operations—basic and diluted | $ | 198 | $ | 74 | ||||||||||
Net income available to ordinary shareholders of Amcor plc from discontinued operations—basic and diluted | $ | — | $ | (8) | ||||||||||
Denominator | ||||||||||||||
Weighted-average ordinary shares outstanding | 1,562.5 | 1,623.5 | ||||||||||||
Weighted-average ordinary shares to be repurchased by Amcor plc | (2.0) | (0.3) | ||||||||||||
Weighted-average ordinary shares outstanding for EPS—basic | 1,560.5 | 1,623.2 | ||||||||||||
Effect of dilutive shares | 4.8 | 2.9 | ||||||||||||
Weighted-average ordinary shares outstanding for EPS—diluted | 1,565.3 | 1,626.1 | ||||||||||||
Per ordinary share income | ||||||||||||||
Income from continuing operations | $ | 0.127 | $ | 0.045 | ||||||||||
Income from discontinued operations | — | (0.005) | ||||||||||||
Basic earnings per ordinary share | $ | 0.127 | $ | 0.041 | ||||||||||
Income from continuing operations | $ | 0.126 | $ | 0.045 | ||||||||||
Income from discontinued operations | — | (0.005) | ||||||||||||
Diluted earnings per ordinary share | $ | 0.126 | $ | 0.041 |
Note: Per share amounts are computed independently for each of the quarters presented. The sum of the quarters may not equal the total year amount due to the impact of changes in average quarterly shares outstanding and all other quarterly amounts may not equal the total year due to rounding.
Certain outstanding share options were excluded from the diluted earnings per share calculation because they were anti-dilutive. The excluded share options for the three months ended September 30, 2020 and 2019 represented an aggregate of 22.8 million and 17.3 million shares, respectively.
26
Note 15 - Contingencies and Legal Proceedings
Contingencies - Brazil
The Company's operations in Brazil are involved in various governmental assessments and litigation, principally related to claims for excise and income taxes. The Company will vigorously defend its positions and believes it will prevail on most, if not all, of these matters. The Company does not believe that the ultimate resolution of these matters will materially impact the Company's consolidated results of operations, financial position or cash flows. Under customary local regulations, the Company's Brazilian subsidiaries may need to post cash or other collateral if a challenge to any administrative assessment proceeds to the Brazilian court system; however, the level of cash or collateral already pledged or potentially required to be pledged would not significantly impact the Company's liquidity. At both September 30, 2020 and June 30, 2020, the Company has recorded an accrual of $12 million, included in other non-current liabilities in the unaudited condensed consolidated balance sheet, and has estimated a reasonably possible loss exposure in excess of the accrual of $18 million. The litigation process is subject to many uncertainties and the outcome of individual matters cannot be accurately predicted. The Company routinely assesses these matters as to probability of ultimately incurring a liability and records the best estimate of the ultimate loss in situations where the likelihood of an ultimate loss is probable. The Company's assessments are based on its knowledge and experience, but the ultimate outcome of any of these matters may differ from the Company's estimates.
As of September 30, 2020, Amcor has provided letters of credit of $33 million, judicial insurance of $1 million, and deposited cash of $10 million with the courts to continue to defend the cases.
Contingencies - Environmental Matters
The Company, along with others, has been identified as a potentially responsible party ("PRP") at several waste disposal sites under U.S. federal and related state environmental statutes and regulations and may face potentially material environmental remediation obligations. While the Company benefits from various forms of insurance policies, actual coverage may not, or only partially, cover the total potential exposures. The Company has recorded $17 million aggregate accruals for its share of estimated future remediation costs at these sites.
In addition to the matters described above, the Company has also recorded aggregate accruals of $46 million for potential liabilities for remediation obligations at various worldwide locations that are owned or operated by the Company, or were formerly owned or operated.
While the Company believes that its accruals are adequate to cover its future obligations, there can be no assurance that the ultimate payments will not exceed the accrued amounts. Nevertheless, based on the available information, the Company does not believe that its potential environmental obligations will have a material adverse effect upon its liquidity, results of operations or financial condition.
Legal Proceedings
Two lawsuits brought by purported holders of Bemis stock against Bemis and Bemis directors and officers are pending in federal court in the U.S. District Court for the Southern District of New York, in which plaintiffs are seeking damages for alleged violations of the Securities Exchange Act of 1934, as amended, and U.S. Securities and Exchange Commission rules and regulations. Plaintiffs allege a failure to adequately disclose information in the proxy statement issued in connection with the Amcor-Bemis merger. The cases are: Dixon, et al. v. Bemis Company, Inc. et al. and Stein v. Bemis Company, Inc. et al., which were instituted on April 15, 2019 and April 17, 2019, respectively. On March 10, 2020 the federal court in the U.S. District Court for the Southern District of New York consolidated the two pending cases into a single class action.
In addition, a purported holder of Bemis stock filed a putative derivative suit in the Cole County Circuit Court, Nineteenth Judicial District of Missouri, against Bemis directors and Amcor, alleging that the directors breached fiduciary duties in connection with the Amcor-Bemis merger and that Amcor aided and abetted breaches of fiduciary duty. The case is Scarantino, et al. v. Amcor Limited, et al., which was instituted on April 19, 2019.
The Company intends to defend the claims made in the pending actions. It is too early for the Company to provide any reliable assessment of the likely quantum of any damages that may become payable if its defense is unsuccessful in whole or in part. Although it is not possible at present to establish a reliable assessment of damages, there can be no assurance that any damages that may be awarded will not be material to the results of operations or financial condition of the Company.
27
Note 16 - Disposals
During the three months ended September 30, 2020, the Company disposed of an equity method investment and other non-core businesses. The Company completed the sale of the equity method investment in AMVIG on September 30, 2020, realizing a net gain of $15 million, which was recorded in the line equity in income (loss) of affiliated companies, net of tax. The Company also completed the disposal of two non-core businesses in India and Argentina in the Flexibles segment during the first quarter of fiscal 2021, recording a loss on sale of $6 million, which was primarily driven by the reclassification of cumulative translation adjustments that had previously been recorded in other comprehensive income.
Note 17 - Subsequent Events
On November 5, 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.1175 per share to be paid on December 15, 2020 to shareholders of record as of November 24, 2020. Amcor has received a waiver from the Australian Securities Exchange ("ASX") settlement operating rules, which will allow Amcor to defer processing conversions between ordinary share and CHESS Depositary Instrument ("CDI") registers from November 23, 2020 to November 24, 2020, inclusive.
On November 5, 2020, the Company's Board of Directors approved a $150 million buyback of ordinary shares and Chess Depositary Instruments ("CDIs"). Pursuant to this program, purchases of the Company's ordinary shares and CDIs will be made subject to market conditions and at prevailing market prices, through open market purchases. The Company expects to complete the share buyback by the end of fiscal year 2021; however, the timing, volume and nature of repurchases may be amended, suspended or discontinued at any time.
28
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis ("M,D&A") should be read in conjunction with the Financial Statements and Notes to Condensed Consolidated Financial Statements. Throughout the M,D&A, amounts and percentages may not recalculate due to rounding.
Summary of Financial Results
Three Months Ended September 30, | ||||||||||||||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||||||||||||||
Net sales | $ | 3,097 | 100.0 | % | $ | 3,141 | 100.0 | % | ||||||||||||||||||
Cost of Sales | (2,443) | (78.9 | %) | (2,594) | (82.6 | %) | ||||||||||||||||||||
Gross profit | 654 | 21.1 | % | 547 | 17.4 | % | ||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
Selling, general, and administrative expenses | (329) | (10.6 | %) | (371) | (11.8 | %) | ||||||||||||||||||||
Research and development expenses | (26) | (0.8 | %) | (26) | (0.8 | %) | ||||||||||||||||||||
Restructuring and related expenses | (23) | (0.7 | %) | (18) | (0.6 | %) | ||||||||||||||||||||
Other income, net | — | — | % | 9 | 0.3 | % | ||||||||||||||||||||
Operating income | 276 | 8.9 | % | 141 | 4.5 | % | ||||||||||||||||||||
Interest income | 3 | 0.1 | % | 7 | 0.2 | % | ||||||||||||||||||||
Interest expense | (40) | (1.3 | %) | (60) | (1.9 | %) | ||||||||||||||||||||
Other non-operating income (loss), net | 3 | 0.1 | % | 8 | 0.3 | % | ||||||||||||||||||||
Income from continuing operations before income taxes and equity in income (loss) of affiliated companies | 242 | 7.8 | % | 96 | 3.1 | % | ||||||||||||||||||||
Income tax expense | (61) | (2.0 | %) | (22) | (0.7 | %) | ||||||||||||||||||||
Equity in income (loss) of affiliated companies | 19 | 0.6 | % | 2 | 0.1 | % | ||||||||||||||||||||
Income from continuing operations | 200 | 6.5 | % | 76 | 2.4 | % | ||||||||||||||||||||
Income (loss) from discontinued operations | — | — | % | (8) | (0.3 | %) | ||||||||||||||||||||
Net income | $ | 200 | 6.5 | % | $ | 68 | 2.2 | % | ||||||||||||||||||
Net (income) loss attributable to non-controlling interests | (2) | (0.1 | %) | (2) | (0.1 | %) | ||||||||||||||||||||
Net income attributable to Amcor plc | $ | 198 | 6.4 | % | $ | 66 | 2.1 | % |
29
Overview
Amcor is a global packaging company with total sales of approximately $12.5 billion in fiscal year 2020. We employ approximately 47,000 people across approximately 230 principal manufacturing sites in more than 40 countries, and are a leader in developing and producing a broad range of packaging products including flexible and rigid packaging, specialty cartons and closures. In fiscal year 2020, the majority of sales were made to the defensive food, beverage, pharmaceutical, medical device, home and personal care, and other consumer goods end markets.
Significant Items Affecting the Periods Presented
Impact of COVID-19
The 2019 Novel Coronavirus ("COVID-19") has resulted in a period of unprecedented uncertainty and challenge. Amcor’s business is almost entirely exposed to defensive end markets which have demonstrated the same resilience experienced through past economic cycles. Our scale and global footprint has enabled us to collaborate with customers and suppliers to meet volatile changes in demand and continue to service our customers. We believe we are well-positioned to meet the challenges of the COVID-19 pandemic. However, we cannot reasonably estimate the duration and severity of this pandemic or its ultimate impact on the global economy and our operations and financial results. The ultimate near-term impact of the pandemic on our business will depend on the extent and nature of any future disruptions across the supply chain, the duration of social distancing measures and other government imposed restrictions and the nature and pace of macroeconomic recovery in key global economies. Our priorities during the COVID-19 pandemic continue to be protecting the health and safety of our employees and effectively managing our operations and supply chains to meet the needs of our customers.
Health and Safety
Amcor’s commitment to the health and safety of its employees remains our first priority. Our rigorous precautionary measures include the formation of global and regional response teams that maintain contact with authorities and experts to actively manage the situation, restrictions on company travel, quarantine protocols for employees who may have had exposure or have symptoms, frequent disinfecting of Amcor locations and other measures designed to help protect employees, customers and suppliers. We expect to continue these measures until the COVID-19 pandemic is adequately contained for our business.
Operations and Supply Chain
We have experienced minimal disruptions to our operations to date as we have largely been deemed as providing essential services. However, we have experienced continued volatility in customer order patterns and could continue to experience significant volatility in the demand for our products in the future. Our facilities have largely been exempt from government mandated closure orders. While governmental measures may be modified, we expect that our facilities will remain operational given the essential products we supply. However, despite our best efforts to contain the impact in our facilities, it remains possible that significant disruptions could occur as a result of the pandemic, including temporary closures of our facilities.
We have not experienced any significant disruptions in our supply chain to date and continue to monitor the risk of customer, raw material and other supply chain disruptions.
2019 Bemis Integration Plan
In connection with the acquisition of Bemis, the Company initiated restructuring activities in the fourth quarter of 2019 aimed at integrating and optimizing the combined organization. As previously announced, the Company continues to target realizing approximately $180 million of pre-tax synergies driven by procurement, supply chain, and general and administrative savings by the end of fiscal year 2022.
The Company's total 2019 Bemis Integration Plan pre-tax integration costs are expected to be approximately $200 million. The total 2019 Bemis Integration Plan costs include $165 million of restructuring and related expenses and $35 million of general integration expenses. The restructuring and related expenses are comprised of approximately $90 million in employee related expenses, $25 million in fixed asset related expenses, $20 million in other restructuring and $30 million in restructuring related expenses. The Company estimates that approximately $150 million of the $200 million total integration costs will result in cash expenditures, of which $115 million relate to restructuring and related expenditures. Cash payments for the three months ended September 30, 2020 were $18 million, of which $14 million were payments related to restructuring and related expenditures. Cash payments of approximately $50 million to $55 million are expected for the balance of the fiscal year with $40 million to $45 million representing payments for restructuring and related expenses. The 2019 Bemis Integration Plan relates to the Flexibles segment and Corporate and is expected to be completed by the end of fiscal year 2022.
30
Restructuring related costs are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. General integration costs are not linked to restructuring. The Company believes the disclosure of restructuring related costs provides more information on the total cost of our 2019 Bemis Integration Plan. The restructuring related costs relate primarily to the closure of facilities and include costs to replace graphics, train new employees on relocated equipment and anticipated loss on sale of closed facilities.
2018 Rigid Packaging Restructuring Plan
On August 21, 2018, the Company announced a restructuring plan in Amcor Rigid Packaging ("2018 Rigid Packaging Restructuring Plan") aimed at reducing structural costs and optimizing the footprint. The Plan includes the closures of manufacturing facilities and headcount reductions to achieve manufacturing footprint optimization and productivity improvements as well as overhead cost reductions.
The Company's total 2018 Rigid Packaging Restructuring Plan pre-tax restructuring costs are expected to be approximately $110 million with the main component being the cost to exit manufacturing facilities and employee related costs. The Company estimates that approximately $70 million of the $110 million total costs will result in cash expenditures. Cash payments for the three months ended September 30, 2020 were $10 million, with approximately $5 million to $10 million expected during the remainder of the fiscal year. The 2018 Rigid Packaging Restructuring Plan is expected to be substantially completed during fiscal 2021.
For more information about our restructuring plans, refer to Note 4, "Restructuring Plans" of "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements".
High Inflation Accounting
We have subsidiaries in Argentina that historically had a functional currency of the Argentine Peso. As of June 30, 2018, the Argentine economy was designated as highly inflationary for accounting purposes. Accordingly, beginning July 1, 2018, we began reporting the financial results of our Argentinean subsidiaries with a functional currency of the Argentine Peso at the functional currency of the parent, which is the U.S. dollar. Highly inflationary accounting in the three months ended September 30, 2020 and 2019 resulted in a negative impact of $4 million and $15 million, respectively, in foreign currency transaction losses that was reflected on the unaudited condensed consolidated statement of income.
31
Results of Operations - Three Months Ended September 30, 2020
Consolidated Results of Operations
Three Months Ended September 30, | ||||||||||||||
($ in millions, except per share data) | 2020 | 2019 | ||||||||||||
Net sales | $ | 3,097 | $ | 3,141 | ||||||||||
Operating income | 276 | 141 | ||||||||||||
Operating profit as a percentage of net sales | 8.9 | % | 4.5 | % | ||||||||||
Net income attributable to Amcor plc | $ | 198 | $ | 66 | ||||||||||
Diluted Earnings Per Share | $ | 0.126 | $ | 0.041 |
Net sales decreased $44 million, or approximately 1%, to $3,097 million for the three months ended September 30, 2020, from $3,141 million for the three months ended September 30, 2019. Excluding negative currency impacts of $23 million, or (0.7%), pass-through of lower raw material costs of $83 million, or (2.6%) and sales from divestitures of $12 million, or (0.4%), the increase in net sales for the three months ended September 30, 2020 was $74 million or 2.3%, driven by favorable volumes of 2.0% and favorable price/mix of 0.3%.
Net income attributable to Amcor plc increased $132 million, or 199%, to $198 million for the three months ended September 30, 2020, from $66 million for the three months ended September 30, 2019 mainly as a result of gross profit increases driven by sales improvement, Bemis acquisition and related transaction and integration cost impacts and associated synergy projects.
Diluted earnings per share increased to $0.126 for the three months ended September 30, 2020, from $0.041 for the three months ended September 30, 2019, with the net income attributable to ordinary shareholders of Amcor plc increasing by 199% and the diluted weighted average number of shares outstanding decreasing 4% for three months ended September 30, 2020 compared to the three months ended September 30, 2019. The decrease in the diluted weighted average number of shares outstanding was due to the prior year $500 million share buyback.
Segment Results of Operations
During the first quarter of fiscal 2021, management has revised the presentation of adjusted earnings before interest and tax ("Adjusted EBIT") from continuing operations in the reportable segments to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. Prior periods have been recast to conform to the new cost allocation methodology. For further discussion, refer to Note 13, "Segments."
Flexibles Segment
Our Flexibles reporting segment develops and supplies flexible packaging globally.
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Net sales including intersegment sales | $ | 2,400 | $ | 2,431 | ||||||||||
Adjusted EBIT from continuing operations | 312 | 283 | ||||||||||||
Adjusted EBIT from continuing operations as a percentage of net sales | 13.0 | % | 11.6 | % |
Net sales including intersegment sales decreased $31 million, or 1%, to $2,400 million for the three months ended September 30, 2020, from $2,431 million for the three months ended September 30, 2019. Excluding negative currency impacts of $7 million, or (0.3%), pass-through of lower raw material costs of $31 million, or (1.3%), and sales from divestitures of $12 million, or (0.5%) the increase in net sales including intersegment sales for the three months ended September 30, 2020 was $19 million, or 0.8%, driven by favorable volumes of 1.5% and unfavorable price/mix of (0.7%).
Adjusted EBIT increased $30 million, or 11%, to $312 million for the three months ended September 30, 2020, from $283 million for the three months ended September 30, 2019. Excluding negative currency impacts of $2 million, or (0.8%), the increase in Adjusted EBIT for the three months ended September 30, 2020 was $32 million, or 11.4%, driven by plant cost improvements of 9.6%, favorable volumes of 3.3%, and favorable selling, general and administrative ("SG&A") and other cost impacts of 2.0%, partially offset by unfavorable price/mix of (3.5%).
32
Rigid Packaging Segment
Our Rigid Packaging reporting segment manufactures rigid packaging containers and related products in the Americas.
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Net sales including intersegment sales | $ | 698 | $ | 711 | ||||||||||
Adjusted EBIT from continuing operations | 72 | 69 | ||||||||||||
Adjusted EBIT from continuing operations as a percentage of net sales | 10.3 | % | 9.7 | % |
Net sales including intersegment sales decreased $13 million, or 2%, to $698 million for the three months ended September 30, 2020, from $711 million for the three months ended September 30, 2019. Excluding negative currency impacts of $16 million, or (2.3%) and pass-through of lower raw material costs of $51 million, or (7.2%), the increase in net sales including intersegment sales for the three months ended September 30, 2020 was $55 million, or 7.7%, driven by favorable volumes of 3.8%, and favorable price/mix of 3.9% including pricing to recover cost inflation in Latin America.
Adjusted EBIT increased $3 million, or 4%, to $72 million for the three months ended September 30, 2020, from $69 million for the three months ended September 30, 2019. Excluding negative currency impacts of $2 million, or (2.9%), the increase in Adjusted EBIT for the three months ended September 30, 2020 was $5 million, or 7.2%, driven by favorable volumes of 5.6%, favorable price/mix of 5.9%, favorable plant costs of 2.6% and favorable SG&A and other costs of 0.9%, partially offset by inventory drawdown impacts of (7.8%).
Consolidated Gross Profit
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Gross profit | $ | 654 | $ | 547 | ||||||||||
Gross profit as a percentage of net sales | 21 | % | 17 | % |
Gross profit increased by $107 million, or 20%, to $654 million for the three months ended September 30, 2020, from $547 million for the three months ended September 30, 2019. The increase was primarily driven by growth in sales volume in the Flexibles and Rigid Packaging reporting segments and a non-recurrence of an inventory fair value adjustment of $58 million in the prior period.
Consolidated Selling, General and Administrative Expense
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
SG&A expenses | $ | (329) | $ | (371) | ||||||||||
SG&A expenses as a percentage of net sales | (11 | %) | (12 | %) |
SG&A expenses decreased by $42 million, or 11%, to $329 million for the three months ended September 30, 2020, from $371 million for the three months ended September 30, 2019. The decrease was primarily due to the impact of synergy projects and reduced integration and related expenses compared with the prior period.
Consolidated Research and Development ("R&D") Expense
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
R&D expenses | $ | (26) | $ | (26) | ||||||||||
R&D expenses as a percentage of net sales | (1 | %) | (1 | %) |
R&D costs decreased $0 million for the three months ended September 30, 2020, from $26 million for the three months ended September 30, 2019.
33
Consolidated Restructuring and Related Expense
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Restructuring and related expenses | $ | (23) | $ | (18) | ||||||||||
Restructuring and related expenses as a percentage of net sales | (1 | %) | (1 | %) |
Restructuring and related expense increased by $5 million to $23 million for the three months ended September 30, 2020, from $18 million for the three months ended September 30, 2019. The increase was primarily driven by a restructuring initiative relating to a plant closure in the Flexibles reporting segment.
Consolidated Other Income, Net
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Other income, net | $ | — | $ | 9 | ||||||||||
Other income, net, as a percentage of net sales | — | % | 0.3 | % |
Other income, net decreased by $9 million to $0 million for the three months ended September 30, 2020, mainly driven by the loss on disposal of two non-core businesses.
Consolidated Interest Income
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Interest income | $ | 3 | $ | 7 | ||||||||||
Interest income as a percentage of net sales | 0.1 | % | 0.2 | % |
Interest income decreased by $4 million to $3 million for the three months ended September 30, 2020, from $7 million for the three months ended September 30, 2019 due to interest rate decreases across cash balances compared to prior period.
Consolidated Interest Expense
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Interest expense | $ | (40) | $ | (60) | ||||||||||
Interest expense as a percentage of net sales | (1 | %) | (2 | %) |
Interest expense decreased by $20 million to $40 million for the three months ended September 30, 2020, from $60 million for the three months ended September 30, 2019, mainly driven by repayment of longer maturity syndicated and term loans with replacement by commercial paper and lower rate debt, together with decreases in rates.
Consolidated Other Non-Operating Income (Loss), Net
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Other non-operating income (loss), net | $ | 3 | $ | 8 | ||||||||||
Other non-operating income (loss), net, as a percentage of net sales | 0.1 | % | 0.3 | % |
Other non-operating income (loss), net decreased by $5 million to a $3 million gain for the three months ended September 30, 2020, from a $8 million gain for the three months ended September 30, 2019, primarily due to defined benefit pension expense changes compared to prior period, including lower return on asset assumptions.
Consolidated Income Tax Expense
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Income tax expense | (61) | (22) | ||||||||||||
Effective income tax rate | 25.2 | % | 22.9 | % |
34
The provision for income taxes is computed by applying the estimated annual effective tax rate to year to date income before income taxes and equity in income of affiliated companies and is adjusted for discrete tax items recorded in the period.
The provision for income taxes for the three months ended September 30, 2020 and 2019 is based on our projected annual effective tax rate for the respective fiscal years, adjusted for specific items that are required to be recognized in the period in which they are incurred.
Income tax expense for the three months ended September 30, 2020 and 2019 is $61 million and $22 million, respectively.
The effective tax rate for the three months ended September 30, 2020 increased by 2.3 percentage points compared to the three months ended September 30, 2019, from 22.9% to 25.2%. The increase in the income tax provision and the effective tax rate was primarily related to lower tax benefits on integration and restructuring costs and the increase of operating income earned in higher tax jurisdictions.
Equity in Income (Loss) of Affiliated Companies, Net of Tax
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Equity in income (loss) of affiliated companies, net of tax | 19 | 2 |
Equity in income (loss) of affiliated companies, net of tax increased by $17 million for the three months ended September 30, 2020 due to the sale of the equity method investment in AMVIG on September 30, 2020. For further information, refer to Note 16, "Disposals."
35
Presentation of Non-GAAP Information
This Quarterly Report on Form 10-Q refers to non-GAAP financial measures: adjusted earnings before interest and taxes ("Adjusted EBIT") from continuing operations, adjusted net income from continuing operations, and net debt. These non-GAAP financial measures adjust for factors that are unusual or unpredictable. These measures exclude the impact of significant tax reform, certain amounts related to the effect of changes in currency exchange rates, acquisitions, and restructuring, including employee-related costs, equipment relocation costs, accelerated depreciation and the write-down of equipment. These measures also exclude gains or losses on sales of significant property and divestitures, certain litigation matters, and certain acquisition-related expenses, including transaction expenses, due diligence expenses, professional and legal fees, purchase accounting adjustments for inventory, order backlog, intangible amortization, and changes in the fair value of deferred acquisition payments. This adjusted information should not be construed as an alternative to results determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Management of the Company uses the non-GAAP measures to evaluate operating performance and believes that these non-GAAP measures are useful to enable investors and other external parties to perform comparisons of current and historical performance of the Company.
A reconciliation of reported net income attributable to Amcor plc to adjusted EBIT from continuing operations and adjusted net income from continuing operations for the three months ended September 30, 2020 and 2019 is as follows:
Three Months Ended September 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | ||||||||||||
Net income attributable to Amcor plc, as reported | $ | 198 | $ | 66 | ||||||||||
Add: Net income (loss) attributable to non-controlling interests | 2 | 2 | ||||||||||||
Less: (Income) loss from discontinued operations, net of tax | — | 8 | ||||||||||||
Income from continuing operations | 200 | 76 | ||||||||||||
Add: Income tax expense | 61 | 22 | ||||||||||||
Add: Interest expense | 40 | 60 | ||||||||||||
Less: Interest income | (3) | (7) | ||||||||||||
EBIT from continuing operations | 298 | 151 | ||||||||||||
Add: Material restructuring programs (1) | 14 | 17 | ||||||||||||
Add: Material acquisition costs and other (2) | 9 | 84 | ||||||||||||
Add: Amortization of acquired intangible assets from business combinations (3) | 41 | 68 | ||||||||||||
Add: Impact of hyperinflation (4) | 4 | 15 | ||||||||||||
Less: Net gain on disposals (5) | (9) | — | ||||||||||||
Adjusted EBIT from continuing operations | $ | 358 | $ | 335 | ||||||||||
Less: Income tax expense | (61) | (22) | ||||||||||||
Add: Adjustments to income tax expense (6) | (10) | (40) | ||||||||||||
Less: Interest expense | (40) | (60) | ||||||||||||
Add: Interest income | 3 | 7 | ||||||||||||
Less: Net (income) loss attributable to non-controlling interests | (2) | (2) | ||||||||||||
Adjusted net income from continuing operations | $ | 247 | $ | 218 |
(1)Material restructuring programs includes the 2018 Rigid Packaging Restructuring Plan and the 2019 Bemis Integration Plan for the three months ended September 30, 2020 and 2019. Refer to Note 4, "Restructuring Plans," for more information about the Company's restructuring plans.
(2)Material acquisition costs and other includes Bemis transaction related costs and integration costs not qualifying as exit costs for the three months ended September 30, 2020. Material acquisition costs and other includes $58 million amortization of Bemis acquisition related inventory fair value step-up and $26 million of Bemis transaction related costs and integration costs not qualifying as exit costs for the three months ended September 30, 2019.
(3)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from acquisitions impacting the periods presented, including $26 million of sales backlog amortization for the three months ended September 30, 2019 from the Bemis acquisition.
(4)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
(5)Net gain on disposals includes the gain realized upon the disposal of AMVIG and other non-core businesses. Refer to Note 16, "Disposals" for more information about the Company's disposals.
(6)Net tax impact on items (1) through (5) above.
36
Reconciliation of Net Debt
A reconciliation of total debt to net debt at September 30, 2020 and June 30, 2020 is as follows:
($ in millions) | September 30, 2020 | June 30, 2020 | ||||||||||||
Current portion of long-term debt | $ | 13 | $ | 11 | ||||||||||
Short-term debt | 225 | 195 | ||||||||||||
Long-term debt, less current portion | 6,361 | 6,028 | ||||||||||||
Total debt | 6,599 | 6,235 | ||||||||||||
Less cash and cash equivalents | 757 | 743 | ||||||||||||
Net debt | $ | 5,842 | $ | 5,492 |
Supplemental Guarantor Information
Amcor plc, along with certain wholly owned subsidiary guarantors, guarantee the following senior notes issued by the wholly owned subsidiaries, Amcor Finance (USA), Inc., Bemis Company, Inc. and Amcor UK Finance plc.
•4.500% Guaranteed Senior Notes due 2021 of Bemis Company, Inc.
•3.100% Guaranteed Senior Notes due 2026 of Bemis Company, Inc.
•2.630% Guaranteed Senior Notes due 2030 of Bemis Company, Inc.
•3.625% Guaranteed Senior Notes due 2026 of Amcor Finance (USA), Inc.
•4.500% Guaranteed Senior Notes due 2028 of Amcor Finance (USA), Inc.
•1.125% Guaranteed Senior Notes due 2027 of Amcor UK Finance plc
The three notes issued by Bemis Company, Inc. are guaranteed by its parent entity Amcor plc and the subsidiary guarantors Amcor Pty Ltd (formerly known as Amcor Limited), Amcor Finance (USA), Inc. and Amcor UK Finance plc. The two notes issued by Amcor Finance (USA), Inc. are guaranteed by its parent entity Amcor plc and the subsidiary guarantors Amcor Pty Ltd, Bemis Company, Inc. and Amcor UK Finance plc. The note issued by Amcor UK Finance plc is guaranteed by its parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Bemis Company, Inc. and Amcor Finance (USA), Inc.
All guarantors fully, unconditionally and irrevocably guarantee, on a joint and several basis, to each holder of the notes the due and punctual payment of the principal of, and any premium and interest on, such note and all other amounts payable, when and as the same shall become due and payable, whether at stated maturity, by declaration of acceleration, call for redemption or otherwise, in accordance with the terms of the notes and related indenture. The obligations of the applicable guarantors under their guarantees will be limited as necessary to recognize certain defenses generally available to guarantors (including those that relate to fraudulent conveyance or transfer, voidable preference, financial assistance, corporate purpose or similar laws) under applicable law. The guarantees will be unsecured and unsubordinated obligations of the guarantors and will rank equally with all existing and future unsecured and unsubordinated debt of each guarantor. None of our other subsidiaries guarantee such notes. The issuers and guarantors conduct large parts of their operations through other subsidiaries of Amcor plc.
Bemis is incorporated in Missouri in the United States, Amcor Finance (USA) Inc. is incorporated in Delaware in the United States, Amcor UK Finance plc is incorporated in England and Wales, United Kingdom and the guarantors are incorporated under the laws of Jersey, Australia, the United States, and England and Wales and, therefore, insolvency proceedings with respect to the issuers and guarantors could proceed under, and be governed by, among others, Jersey, Australian, United States or English insolvency law, as the case may be, if either issuer or any guarantor defaults on its obligations under the applicable Notes or Guarantees, respectively.
Set forth below is the summarized financial information of the combined obligor group made up of Amcor plc (as parent guarantor), Bemis Company, Inc., Amcor Finance (USA), Inc. and Amcor UK Finance plc (as subsidiary issuers of the notes and guarantors of each other’s notes) and Amcor Pty Ltd (as the remaining subsidiary guarantor).
37
Basis of Preparation
Amcor has voluntarily adopted amendments to the financial disclosure requirements for guarantors and issuers of guaranteed securities registered or being registered as issued by the SEC [Release No. 33-10762; 34-88307; File No. S7-19-18] in March 2020. The following summarized financial information is presented for the parent, issuer, and guarantor subsidiaries ("Obligor Group") on a combined basis after elimination of intercompany transactions between entities in the combined group and amounts related to investments in any subsidiary that is a non-guarantor.
This information is not intended to present the financial position or results of operations of the combined group of companies in accordance with U.S. GAAP.
Statement of Income for Obligor Group
($ in millions) | Three Months Ended September 30, 2020 | |||||||
Net sales - external | $ | 234 | ||||||
Net sales - to subsidiaries outside the Obligor Group | 2 | |||||||
Total net sales | 236 | |||||||
Gross profit | 45 | |||||||
Income from continuing operations (1) | (26) | |||||||
Income (loss) from discontinued operations, net of tax | — | |||||||
Net income | $ | (26) | ||||||
Net (income) loss attributable to non-controlling interests | — | |||||||
Net income attributable to Obligor Group | $ | (26) |
(1)Includes $110 million net income from subsidiaries outside the Obligor Group mainly made up of intercompany dividend and interest income.
Balance Sheet for Obligor Group
(in millions) | September 30, 2020 | June 30, 2020 | ||||||||||||
Assets | ||||||||||||||
Current assets - external | $ | 667 | $ | 899 | ||||||||||
Current assets - due from subsidiaries outside the Obligor Group | 70 | 136 | ||||||||||||
Total current assets | 737 | 1,035 | ||||||||||||
Non-current assets - external | 993 | 1,002 | ||||||||||||
Non-current assets - due from subsidiaries outside the Obligor Group | 12,740 | 12,405 | ||||||||||||
Total non-current assets | 13,733 | 13,407 | ||||||||||||
Total assets | $ | 14,470 | $ | 14,443 | ||||||||||
Liabilities | ||||||||||||||
Current liabilities - external | $ | 1,433 | $ | 1,647 | ||||||||||
Current liabilities - due from subsidiaries outside the Obligor Group | 16 | 36 | ||||||||||||
Total current liabilities | 1,449 | 1,683 | ||||||||||||
Non-current liabilities - external | 6,408 | 6,074 | ||||||||||||
Non-current liabilities - due from subsidiaries outside the Obligor Group | 11,331 | 11,201 | ||||||||||||
Total non-current liabilities | 17,739 | 17,274 | ||||||||||||
Total liabilities | $ | 19,188 | $ | 18,957 |
38
New Accounting Pronouncements
Refer to Note 2, "New Accounting Guidance," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements."
Critical Accounting Estimates and Judgments
Our discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Our estimates and judgments are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. These critical accounting estimates are discussed in detail in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates and Judgments” in our Annual Report on Form 10-K for the year ended June 30, 2020.
39
Liquidity and Capital Resources
We finance our business primarily through cash flows provided by operating activities, borrowings from banks and proceeds from issuances of debt and equity. We periodically review our capital structure and liquidity position in light of market conditions, expected future cash flows, potential funding requirements for debt refinancing, capital expenditures and acquisitions, the cost of capital, sensitivity analyses reflecting downside scenarios, the impact on our financial metrics and credit ratings, and our ease of access to funding sources.
Based on our current and expected cash flow from operating activities and available cash, we believe our cash flows provided by operating activities, together with borrowings available under our credit facilities, will continue to provide sufficient liquidity to fund our operations, capital expenditures and other commitments, including dividends, into the foreseeable future.
During the first quarter of fiscal 2021, the company repaid €100 million Euro Private Placement Notes on September 1, 2020.
Despite the existing market uncertainties and volatilities stemming from the COVID-19 pandemic, based on our current and expected cash flow from operating activities and available cash, we believe our cash flows provided by operating activities, together with borrowings available under our credit facilities and access to the commercial paper market back stopped by our bank facilities, will continue to provide sufficient liquidity to fund our operations, capital expenditures and other commitments, including dividends and purchases of our ordinary shares and CHESS Depositary Instruments under authorized share repurchase programs, into the foreseeable future.
Overview
Three Months Ended September 30, | ||||||||||||||||||||
($ in millions) | 2020 | 2019 | Change 1Q 2021 vs. 1Q 2020 | |||||||||||||||||
Cash flow from operating activities | $ | (110) | $ | (89) | $ | (21) | ||||||||||||||
Cash flow from investing activities | 27 | 284 | (257) | |||||||||||||||||
Cash flow from financing activities | 76 | (306) | 382 |
Cash Flow Overview
Cash Flow from Operating Activities
Net cash outflows used in operating activities increased by $21 million, or 23%, to $110 million for the three months ended September 30, 2020, from $89 million for the three months ended September 30, 2019. The increase was mainly driven by inflows from increased net income offset by working capital outflows.
Cash Flow from Investing Activities
Net cash inflows provided by investing activities decreased by $257 million, or 91%, to $27 million for the three months ended September 30, 2020, from a $284 million inflow for the three months ended September 30, 2019. This decrease was primarily due to higher disposal proceeds in the prior period mainly from the EC Remedy related to the Bemis acquisition.
Cash Flow from Financing Activities
Net cash flows from financing activities increased by $382 million to $76 million for the three months ended September 30, 2020, from a $306 million outflow for the three months ended September 30, 2019. This increase was primarily due to higher net debt repayments in the prior period, partially offset by dividend payments in the current period.
Net Debt
We borrow money from financial institutions and debt investors in the form of bank overdrafts, bank loans, corporate bonds, unsecured notes and commercial paper. We have a mixture of fixed and floating interest rates and use interest rate swaps to provide further flexibility in managing the interest cost of borrowings.
40
Short-term debt consists of bank debt with a duration of less than 12 months and bank overdrafts which are classified as current due to the short-term nature of the borrowings, except where we have the ability and intent to refinance and as such extend the debt beyond 12 months. The current portion of the long-term debt, except where we have the ability and intent to refinance, consists of debt amounts repayable within a year after the balance sheet date.
Our primary bank debt facilities and notes are unsecured and subject to negative pledge arrangements limiting the amount of secured indebtedness we can incur to a range between 7.5% to 15.0% of our total tangible assets, subject to some exceptions and variations by facility. In addition, the bank debt facilities and U.S. private placement debt require us to comply with certain financial covenants, including leverage and interest coverage ratios. The negative pledge arrangements and the financial covenants are defined in the related debt agreements. As of September 30, 2020, we were in compliance with all applicable covenants under our bank debt facilities and U.S. private placement debt.
Our net debt as of September 30, 2020 and June 30, 2020 was $5.8 billion and $5.5 billion, respectively.
Available Financing
As of September 30, 2020, we had undrawn credit facilities available in the amount of $1.4 billion. Our senior facilities are available to fund working capital, growth capital expenditures and refinancing obligations and are provided to us by four separate bank syndicates.
As of September 30, 2020, the revolving senior bank debt facilities had an aggregate limit of $4.2 billion, of which $2.8 billion had been drawn (inclusive of amounts drawn under commercial paper programs reducing the overall balance of available senior facilities). Our senior facilities mature between fiscal years 2022 and 2024.
Dividend Payments
During the three months ended September 30, 2020, we declared and paid a $0.115 cash dividend per ordinary share.
Credit Rating
Our capital structure and financial practices have earned us investment grade credit ratings from two internationally recognized credit rating agencies. These credit ratings are important to our ability to issue debt at favorable rates of interest, for various tenors and from a diverse range of markets that are highly liquid, including European and U.S. debt capital markets and from global financial institutions.
Share Repurchases
We had cash outflows of zero and $10 million for the purchase of our shares in the open market during the three months ended September 30, 2020 and 2019, respectively, as treasury shares to satisfy the vesting and exercises of share-based compensation awards. As of September 30, 2020, and June 30, 2020, we held treasury shares at cost of $49 million and $67 million, representing 4.9 million and 6.7 million shares, respectively.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in our market risk during the three months ended September 30, 2020. For additional information, refer to Note 7, "Fair Value Measurements," and Note 8, "Derivative Instruments," to the notes to our unaudited condensed consolidated financial statements and to "Item 7A. - Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the year ended June 30, 2020.
41
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2020. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation conducted, our Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were not effective as of September 30, 2020, due to the existence of a material weakness in our internal control over financial reporting that was identified in our prospectus filed with the SEC on March 25, 2019 and is still being remediated, as described below.
Material Weakness in Internal Control Over Financial Reporting
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement in our annual or interim financial statements will not be prevented or detected on a timely basis.
As previously disclosed, we identified a material weakness arising from deficiencies in the design and operating effectiveness of internal controls over the period end reporting process. Specifically, we did not design and maintain effective controls to verify that conflicting duties were appropriately segregated within key IT systems used in the preparation and reporting of financial information. This control deficiency did not result in a misstatement of our consolidated financial statements. However, the control deficiency could have resulted in misstatements of our interim or annual consolidated financial statements and disclosures that may have not been prevented or detected on a timely basis.
Remediation Efforts to Address Material Weakness
We are currently in the process of remediating the material weakness described above through a process to (i) develop and implement additional controls and procedures to reduce the number of segregation of duties conflicts within key IT systems, which includes the implementation of new security roles and the automation of segregation of duties monitoring where practical, (ii) design and implement additional compensating controls where necessary and (iii) develop training on segregation of duties. Given we operate many ERP systems globally, this effort targeted the largest locations with standardized systems in fiscal 2020 and is being expanded to additional locations in fiscal 2021. These enhanced processes, including the implementation of new mitigating controls, will effectively remediate the material weakness, but the material weakness will not be considered remediated until the revised controls operate for a sufficient period of time and we have concluded, through testing in the second half of fiscal year 2021, that they are designed and operating effectively. We currently expect that the remediation of this material weakness will be fully remediated by the end of fiscal 2021. However, there is no assurance that this material weakness will be fully remediated by the end of fiscal 2021 given the severity and length of the 2019 Novel Coronavirus ("COVID-19") pandemic is unknown and the remediation timeline, while not significantly impacted to date, could be negatively impacted because of inefficiencies caused by COVID-19 limitations on travel, meetings and on-site work.
a)Changes in Internal Control Over Financial Reporting
Except as described above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the first fiscal quarter of 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
42
Part II - Other Information
Item 1. Legal Proceedings
The material set forth in Note 15, "Contingencies and Legal Proceedings," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements" is incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes from the risk factors contained in "Item 1A. - Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
During the three months ended September 30, 2020, the Company did not repurchase any shares.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.
43
Item 6. Exhibits
The documents in the accompanying Exhibits Index are filed, furnished or incorporated by reference as part of this Quarterly Report on Form 10-Q, and such Exhibits Index is incorporated herein by reference.
Exhibit | Description | Form of Filing | |||||||||||||||
22 | Filed Herewith | ||||||||||||||||
31 | .1 | Filed Herewith | |||||||||||||||
31 | .2 | Filed Herewith | |||||||||||||||
32 | Furnished Herewith | ||||||||||||||||
101 | .INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document. | Filed Electronically | ||||||||||||||
101 | .SCH | Inline XBRL Taxonomy Extension Schema Document. | Filed Electronically | ||||||||||||||
101 | .CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | Filed Electronically | ||||||||||||||
101 | .DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | Filed Electronically | ||||||||||||||
101 | .LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | Filed Electronically | ||||||||||||||
101 | .PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | Filed Electronically | ||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | Filed Electronically |
44
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AMCOR PLC | |||||||||||
Date | November 6, 2020 | By | /s/ Michael Casamento | ||||||||
Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||||||||||
Date | November 6, 2020 | By | /s/ Julie Sorrells | ||||||||
Julie Sorrells, Vice President and Corporate Controller (Principal Accounting Officer) |
45